Skip to Content
Merck
CN

Chemical modification of reveromycin A and its biological activities.

Bioorganic & medicinal chemistry letters (2002-11-07)
Takeshi Shimizu, Takeo Usui, Kiyotaka Machida, Kouichi Furuya, Hiroyuki Osada, Tadashi Nakata
ABSTRACT

Various derivatives of reveromycin A, a novel inhibitor of eukaryotic cell growth, were prepared and their inhibitory effects on both isoleucyl-tRNA synthetase activity and in vitro protein synthesis, and activities on the morphological reversion of src(ts)-NRK cells were assayed. The C5 hydroxyl group and C24 carboxyl group are particularly important for these activities.